berberine has been researched along with Neurodegenerative Diseases in 17 studies
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neurodegenerative disorders are heterogeneous diseases associated with either acute or progressive neurodegeneration, causing the loss of neurons and axons in the central nervous system (CNS), showing high morbidity and mortality, and there are only a few effective therapies." | 6.66 | AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases. ( Fang, Y; Gong, Y; Guo, Y; Huang, J; Li, S; Li, W; Liu, Y; Qin, S; Tang, H; Wang, S; Xu, Z; Yuan, W, 2020) |
| "Neurodegenerative diseases are among the most serious health problems affecting millions of people worldwide." | 6.61 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential. ( Cao, M; Fan, D; Liu, L; Wu, Z, 2019) |
| "Berberine (BBR) is an organic small molecule isolated from various plants that have been used in traditional Chinese medicine." | 6.52 | Therapeutic potential of berberine against neurodegenerative diseases. ( Jiang, W; Li, S; Li, X, 2015) |
| "Demethyleneberberine is a metabolite of berberine that has better blood-brain barrier crossing capacity." | 2.82 | Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight. ( Grewal, AK; Gupta, S; Khan, H; Saklani, P; Singh, TG, 2022) |
| "Berberine is an isoquinoline alkaloid that has shown promise as a pharmacological treatment in PD, given its ability to modulate several molecular pathway associated with the disease." | 2.82 | Can Berberine Serve as a New Therapy for Parkinson's Disease? ( Aschner, M; Dadgostar, E; Khandan, M; Mirzaei, H; Moghanlou, M; Mohammadi, S; Parvaresh, M; Tamtaji, OR, 2022) |
| "Neurodegenerative disorders are heterogeneous diseases associated with either acute or progressive neurodegeneration, causing the loss of neurons and axons in the central nervous system (CNS), showing high morbidity and mortality, and there are only a few effective therapies." | 2.66 | AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases. ( Fang, Y; Gong, Y; Guo, Y; Huang, J; Li, S; Li, W; Liu, Y; Qin, S; Tang, H; Wang, S; Xu, Z; Yuan, W, 2020) |
| "Berberine is a plant metabolite belonging to the group of isoquinoline alkaloids with strong biological and pharmacological activity." | 2.66 | Biological Activity of Berberine-A Summary Update. ( Nowak, R; Och, A; Podgórski, R, 2020) |
| "Neurodegenerative diseases are among the most serious health problems affecting millions of people worldwide." | 2.61 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential. ( Cao, M; Fan, D; Liu, L; Wu, Z, 2019) |
| "Berberine (BBR) is an organic small molecule isolated from various plants that have been used in traditional Chinese medicine." | 2.52 | Therapeutic potential of berberine against neurodegenerative diseases. ( Jiang, W; Li, S; Li, X, 2015) |
| "Berberine is an isoquinoline alkaloid, widely present in different medicinal herbs, especially in the genus Berberis." | 2.52 | Berberine and neurodegeneration: A review of literature. ( Abdollahi, M; Ahmed, T; Daglia, M; Gilani, AU; Nabavi, SF; Nabavi, SM, 2015) |
| "Berberine (BBR) is a natural alkaloid extracted from the herb Coptis chinensis." | 1.91 | Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice. ( Chen, J; Chen, M; Feng, W; Li, X; Li, Y; Liu, Q; Liu, X; Tian, J; Wang, C, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 10 (58.82) | 2.80 |
| Authors | Studies |
|---|---|
| Saklani, P | 1 |
| Khan, H | 1 |
| Singh, TG | 1 |
| Gupta, S | 2 |
| Grewal, AK | 1 |
| Dadgostar, E | 1 |
| Moghanlou, M | 1 |
| Parvaresh, M | 1 |
| Mohammadi, S | 1 |
| Khandan, M | 1 |
| Aschner, M | 1 |
| Mirzaei, H | 1 |
| Tamtaji, OR | 1 |
| Islam, F | 1 |
| Islam, MM | 1 |
| Khan Meem, AF | 1 |
| Nafady, MH | 1 |
| Islam, MR | 1 |
| Akter, A | 1 |
| Mitra, S | 1 |
| Alhumaydhi, FA | 1 |
| Emran, TB | 1 |
| Khusro, A | 1 |
| Simal-Gandara, J | 1 |
| Eftekhari, A | 1 |
| Karimi, F | 1 |
| Baghayeri, M | 1 |
| Shen, R | 3 |
| Chen, Y | 5 |
| Li, X | 5 |
| Wang, X | 3 |
| Yang, A | 3 |
| Kou, X | 3 |
| Chen, J | 2 |
| Feng, W | 1 |
| Wang, C | 1 |
| Chen, M | 1 |
| Li, Y | 2 |
| Liu, X | 1 |
| Liu, Q | 1 |
| Tian, J | 1 |
| Qin, S | 1 |
| Tang, H | 1 |
| Li, W | 1 |
| Gong, Y | 1 |
| Li, S | 2 |
| Huang, J | 1 |
| Fang, Y | 1 |
| Yuan, W | 1 |
| Liu, Y | 1 |
| Wang, S | 1 |
| Guo, Y | 2 |
| Xu, Z | 1 |
| Och, A | 1 |
| Podgórski, R | 1 |
| Nowak, R | 1 |
| Liang, Y | 1 |
| Ye, C | 1 |
| Diao, S | 1 |
| Huang, M | 1 |
| Khan, A | 1 |
| Vishwas, S | 1 |
| Gulati, M | 1 |
| Gurjeet Singh, T | 1 |
| Dua, K | 1 |
| Kumar Singh, S | 1 |
| Najda, A | 1 |
| Sayed, AA | 1 |
| Almeer, R | 1 |
| Abdel-Daim, MM | 1 |
| Mohi-Ud-Din, R | 1 |
| Mir, RH | 1 |
| Wani, TU | 1 |
| Shah, AJ | 1 |
| Banday, N | 1 |
| Pottoo, FH | 1 |
| McCubrey, JA | 1 |
| Lertpiriyapong, K | 1 |
| Steelman, LS | 1 |
| Abrams, SL | 1 |
| Cocco, L | 1 |
| Ratti, S | 1 |
| Martelli, AM | 1 |
| Candido, S | 1 |
| Libra, M | 1 |
| Montalto, G | 1 |
| Cervello, M | 1 |
| Gizak, A | 1 |
| Rakus, D | 1 |
| Fan, D | 1 |
| Liu, L | 1 |
| Wu, Z | 1 |
| Cao, M | 1 |
| Soudi, SA | 1 |
| Nounou, MI | 1 |
| Sheweita, SA | 1 |
| Ghareeb, DA | 1 |
| Younis, LK | 1 |
| El-Khordagui, LK | 1 |
| Liu, P | 1 |
| Qi, X | 1 |
| Xu, J | 1 |
| Liu, D | 1 |
| Ji, X | 1 |
| Chi, T | 1 |
| Liu, H | 1 |
| Zou, L | 1 |
| Jiang, W | 1 |
| Ahmed, T | 1 |
| Gilani, AU | 1 |
| Abdollahi, M | 1 |
| Daglia, M | 1 |
| Nabavi, SF | 1 |
| Nabavi, SM | 1 |
| Zhang, J | 1 |
| Yang, JQ | 1 |
| He, BC | 1 |
| Zhou, QX | 1 |
| Yu, HR | 1 |
| Tang, Y | 1 |
| Liu, BZ | 1 |
10 reviews available for berberine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight.
Topics: Alkaloids; AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Berberine; Humans; | 2022 |
Can Berberine Serve as a New Therapy for Parkinson's Disease?
Topics: alpha-Synuclein; Autophagy; Berberine; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Oxi | 2022 |
Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases.
Topics: Berberine; Curcumin; Genistein; Humans; Luteolin; Neurodegenerative Diseases; Nitrogen; Oxygen; Poly | 2022 |
AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases.
Topics: AMP-Activated Protein Kinases; Autophagy; Berberine; Humans; Neurodegenerative Diseases; Phosphatidy | 2020 |
Biological Activity of Berberine-A Summary Update.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Berberine; Cardiovascular Diseases; Drug R | 2020 |
Berberine in the Treatment of Neurodegenerative Diseases and Nanotechnology Enabled Targeted Delivery.
Topics: Animals; Apoptosis; Berberine; Mice; Nanotechnology; Neurodegenerative Diseases; Reactive Oxygen Spe | 2022 |
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
Topics: Berberine; Cardiovascular Diseases; Curcumin; Gene Expression Regulation; Glycogen Synthase Kinase 3 | 2017 |
Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
Topics: Animals; Apoptosis; Autophagy; Berberine; Humans; Neurodegenerative Diseases; Neurons; Oxidative Str | 2019 |
Therapeutic potential of berberine against neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Berberine; Blood-Brain Barrier; Disease Models, Animal; Humans; Medicine | 2015 |
Berberine and neurodegeneration: A review of literature.
Topics: Animals; Antioxidants; Berberine; Berberis; Humans; Neurodegenerative Diseases; Oxidative Stress | 2015 |
7 other studies available for berberine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent.
Topics: Alzheimer Disease; Animals; Berberine; Caenorhabditis elegans; Drugs, Chinese Herbal; Humans; Neurod | 2023 |
Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent.
Topics: Alzheimer Disease; Animals; Berberine; Caenorhabditis elegans; Drugs, Chinese Herbal; Humans; Neurod | 2023 |
Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent.
Topics: Alzheimer Disease; Animals; Berberine; Caenorhabditis elegans; Drugs, Chinese Herbal; Humans; Neurod | 2023 |
Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent.
Topics: Alzheimer Disease; Animals; Berberine; Caenorhabditis elegans; Drugs, Chinese Herbal; Humans; Neurod | 2023 |
Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice.
Topics: Alzheimer Disease; Animals; Berberine; Brain; Ferroptosis; Iron; Kelch-Like ECH-Associated Protein 1 | 2023 |
Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer's Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2021 |
Demethyleneberberine: A possible treatment for Huntington's disease.
Topics: Berberine; Humans; Huntington Disease; Neurodegenerative Diseases; Oxidative Stress | 2021 |
Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Berberine; Brain; Chitosan; Glucose; Glutathio | 2019 |
Protein kinase C is involved in the neuroprotective effect of berberine against intrastriatal injection of quinolinic acid-induced biochemical alteration in mice.
Topics: Animals; Berberine; Cognitive Dysfunction; Disease Models, Animal; Glutamic Acid; Glycogen Synthase | 2019 |
Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease.
Topics: Aluminum; Animals; Berberine; Brain Injuries; Disease Models, Animal; Drugs, Chinese Herbal; Male; N | 2009 |